Fact CheckerSign in

NCT06840587Recruiting

Connect-Home: Alzheimer's Disease and Related Dementias

Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
360 (estimated)
First submitted
17 Feb 2025
Start date
4 Apr 2025
Primary completion date
30 Jun 2027
Lead sponsor
University of North Carolina, Chapel Hill
NCT number
NCT06840587

What you commit to

  • Study type: Interventional
  • Planned participants: 360
  • From 4 Apr 2025 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients:
  • Planned hospital readmission for procedures or treatments within 30 days post enrollment.
    • Caregivers:
  • LAR is a court-appointed guardian.

Who the study is looking for

  • Patients:
  • Ability to speak English
  • Goal of discharge to home, assisted living, or long-term care
  • Diagnosis of dementia
  • Having a caregiver willing to participate
    • Caregivers:
  • Ability to speak English
  • Legally authorized representative (LAR) who also provides support for the person with ADRD
  • Location within 120 miles of UNC-Chapel Hill
  • Admission of at least 75 SNF patients per year

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of North Carolina at Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.